medigraphic.com
ISSN 1561-3054 (Electronic)

2022, Number 2

<< Back Next >>

Rev Cubana Med Trop 2022; 74 (2)

Inactivation of Zika virus with nucleic acids transport media, potentially applicable to clinical samples for the molecular diagnosis of SARS-CoV-2

Montalvo VMC, Labrada RA, Valdés RO, Álvarez VM, Santana AE, Medero DD, Wilson JC, López HD, Nuñez QL, Sánchez DY, Naranjo GC, Chuairey RW, Aleaga SY, Rodríguez LLA, Guzmán TMG

Language: Spanish
References: 15
Page:
PDF size: 273.53 Kb.


ABSTRACT

Introduction: Collection media of clinical samples with the capacity to denature viruses reduce the risk of contagion during transportation and processing.
Objective: To use the nucleic acids transport media (NATM) in nasopharyngeal swab samples collected for the diagnosis of SARS-CoV-2.
Methods: An experimental study was conducted to demonstrate the medium capacity to inactivate viral infectivity. Zika virus (ZIKV), of biosafety level 2, was used as an enveloped virus model. The clinical performance of the NATM for the diagnosis of SARS-CoV-2 was evaluated. A ZIKV strain propagated in the Vero cell line was used and, prior to cells infection, ZIKV was in contact at different intervals (2; 15, and 30 min) with pure NATM; subsequently, serial dilutions (10-1-10-4) were performed. Viral inactivation was evaluated by RT-PCR in the supernatant and the collected cells when the propagation period was completed. CITOSWAB® VTM was used as reference to estimate the clinical performance of the NATM in 30 nasopharyngeal swabs collected for the diagnosis of SARS-CoV-2 infection.
Results: ZIKV remained infectious at inoculum dilutions of ≥ 10-2, regardless of contact time. Clinical specificity and sensitivity of the NATM for the diagnosis of SARS-CoV-2 were 100%, respectively.
Conclusions: Results suggest that ZIKV positive clinical samples at dilutions ≤ 10-1 of the NATM can be safely handled, which could potentially be applied to the molecular diagnosis of SARS-CoV-2.


REFERENCES

  1. Richard-Greenblatt M, Comar CE, Flevaud L, Berti M, Harris RM, Weiss SR, et al. Copan eNAT transport systemto address challenges in COVID-19 diagnostics in regions with limited testing access. J Clin Microbiol. 2021;59:e00110-21. DOI: https://doi.org/10.1128/JCM.00110-211.

  2. Welch SR, Davies KA, Buczkowski H, Hettiarachchi N, Green N, Arnold U, et al. Analysis of Inactivation of SARS-CoV-2 by Specimen Transport Media, Nucleic Acid Extraction Reagents, Detergents, and Fixatives. J Clin Microbiol. 2020;58(11):e01713-20. DOI: https://doi.org/10.1128/JCM.01713-202.

  3. World Health Organization. Laboratory testing for coronavirus disease (COVID-19) in suspected human cases: interim guidance, 19 March 2020. World Health Organization, 2020b.

  4. Blow J, Dohm DJ, Negley DL, Mores CN. Virus inactivation by nucleic acid extraction reagents. J Virol Methods. 2004;119:195-8. DOI: https://doi.org/10.1016/j.jviromet.2004.03.0154.

  5. Lanciotti RS, Kosoy OL, Laven JJ, Velez JO, Lambert AJ, Johnson AJ, et al. Genetic and Serologic Properties of Zika Virus Associated with an Epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis. 2008;14(8):1232-9. DOI: https://doi.org/10.3201/eid1408.0802875.

  6. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd ed. New York. Cold Spring Harbor. 1989; p. 9.14-9.19.

  7. Kochel TJ, Kocher GA, Ksiazek TG, Burans JP. Evaluation of TRIzol LS Inactivation of Viruses. J ABSA Inter. 2017;22(2):52-5.

  8. Yang HJ, Tsou CL. Inactivation during denaturation of Ribonuclease A by Guanidinium Chloride is accompanied by unfolding at the active site. Biochem J. 1995;305:379-384.

  9. Chan SY, Ma MC, Goldsmith MA. Differential induction of cellular detachment by envelope glicoproteins of Marburg and Ebola (Zaire) viruses. J Gen Virol. 2000;83:2155-9.

  10. Ding N, Craik SA, Pang X, Lee B, Neumann NF. Assessing UV Inactivation of Adenovirus 41 Using Integrated Cell Culture Real-Time qPCR/RT-qPCR. Water Envioront Res. 2017;89(4):323-329. DOI: https://doi.org/10.2175/106143017X1483999452302810.

  11. Jureka AS, Silvas JA, Basler CF. Propagation, Inactivation, and Safety Testing of SARS-CoV-2. Viruses. 2000;12:622. DOI: https://doi.org/10.3390/v1206062211.

  12. Amirouche A, Ait-Ali D, Nouri H, Boudrahme-Hannou L, Tliba S, Ghidouche A, et al. TRIzol-based RNA extraction for detection protocol for SARS-CoV-2 of coronavirus disease 2019. New Microb. 2021;41(C):100874. DOI: https://doi.org/10.1016/j.nmni.2021.10087412.

  13. Carvalho AF, Gonçalves AP, Souza TB, Sato HT, Vuitika L. The use of denaturing solution as collection and transport media to improve SarS-CoV-2 RNA detection and reduce infection of laboratory personnel. MedRxiv preprint. 2020. DOI: https://doi.org/10.1101/2020.06.18.2013430413.

  14. Daum LT, Choi Y, Worthy SA, Rodriguez JD, Chambers JP, Fischer GW. A molecular transport medium for collection, inactivation, transport, and detection of Mycobacterium tuberculosis. Int J Tuberc Lung Dis. 2014;18(7):847-9.

  15. Schlaudecker EP, Heck JP, MacIntyre ET, Martinez R, Dodd CN, McNeal MM, et al. Comparison of a new transport medium with universal transport medium at a tropical field site. Diagn Microbiol Infect Dis. 2014;80(2):107-10. DOI: https://doi:10.1016/j.diagmicrobio.2014.05.01815.




2020     |     www.medigraphic.com